BRIEF published on 06/03/2024 at 21:04, 1 year 9 months ago Ikonisys Completes Capital Increase to Boost Commercial Expansion Private Placement Capital Increase Commercial Expansion Ikonisys Hospitex Integration
PRESS RELEASE published on 06/03/2024 at 20:59, 1 year 9 months ago Informations privilégiées / Autres communiqués Ikonisys réalise une augmentation de capital par le biais d'un placement privé pour accélérer son développement commercial. L'émission de 100 000 actions nouvelles permettra de renforcer ses ressources financières Placement Privé Augmentation De Capital Actions Nouvelles Développement Commercial Ikonisys
PRESS RELEASE published on 06/03/2024 at 20:59, 1 year 9 months ago Inside Information / Other news releases Ikonisys announces €150k capital increase through private placement to accelerate commercial development. New funds strengthen financial resources for expansion Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
BRIEF published on 05/30/2024 at 07:35, 1 year 9 months ago Ikonisys Launches New Website to Promote FISH Technology and Total Automation in Healthcare Automation Healthcare Ikonisys FISH Technology Mass Screening
BRIEF published on 05/30/2024 at 07:35, 1 year 9 months ago Ikonisys lance un nouveau site Web pour promouvoir la technologie FISH et l'automatisation totale des soins de santé Automatisation Soins De Santé Ikonisys Technologie POISSON Dépistage De Masse
PRESS RELEASE published on 05/30/2024 at 07:30, 1 year 9 months ago Inside Information / Other news releases Ikonisys launches new website focusing on FISH technology and total automation in healthcare, enhancing mass cancer screening with advanced solutions and seamless integration Healthcare Ikonisys FISH Technology Mass Screening Total Automation
BRIEF published on 05/15/2024 at 07:35, 1 year 10 months ago Ikonisys: New international patent for Hospitex Ikonisys BLOCKfast Hospitalex International International Patent Cancer Diagnosis
BRIEF published on 05/15/2024 at 07:35, 1 year 10 months ago Ikonisys : Nouveau brevet international pour Hospitex Ikonisys Hospitex International BLOCKfast Brevet International Diagnostic Du Cancer
PRESS RELEASE published on 05/15/2024 at 07:30, 1 year 10 months ago Inside Information / Other news releases Hospitex International obtains international patent for BLOCKfast cyto-inclusion kit, enhancing global cancer diagnosis solutions. Company offers innovative diagnostics solutions in cytology Hospitex International BLOCKfast Cyto-inclusion Kit Global Commercial Development Cancer Diagnosis Solutions Cytology Diagnostics
PRESS RELEASE published on 05/15/2024 at 07:30, 1 year 10 months ago Informations privilégiées / Autres communiqués Hospitex obtient un brevet international pour kit cytoinclusion BLOCKfast, produit phare utile en anatomie pathologique, ouvrant perspectives de développement commercial mondial Hospitex Développement Commercial BLOCKfast Brevet International Diagnostic Cancer
Published on 03/26/2026 at 04:55, 2 hours 35 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 6 hours 50 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 7 hours ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 12 hours 15 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 18 hours ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/26/2026 at 07:11, 18 minutes ago Berentzen-Gruppe Aktiengesellschaft publishes its 2025 Annual Report – Berentzen Group achieves significant consolidated profit
Published on 03/26/2026 at 07:07, 22 minutes ago Heidelberg Pharma Announces Financial Figures and Reports on Business Performance in 2025 and Outlook for 2026
Published on 03/26/2026 at 07:05, 24 minutes ago Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
Published on 03/26/2026 at 07:05, 25 minutes ago EDAG Group: Market uncertainty and delayed awarding of projects shape FY 2025 – Strategic measures accelerated to restore sustainable growth and competitiveness
Published on 03/26/2026 at 07:00, 29 minutes ago WashTec AG: New record revenue of €498.6m with further increase in EBIT margin to 9.8% - at con-stant exchange rates revenue exceeds €500m for the first time
Published on 03/25/2026 at 18:53, 12 hours 36 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 12 hours 58 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 12 hours 58 minutes ago Performance soutenue des Investissements et déploiement actif de la stratégie
